[Soft-tissue sarcoma: recent developments]

Dtsch Med Wochenschr. 2012 Aug;137(31-32):1556-9. doi: 10.1055/s-0032-1305149. Epub 2012 Aug 7.
[Article in German]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Administration, Oral
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Clinical Trials, Phase III as Topic
  • Combined Modality Therapy
  • Dacarbazine / administration & dosage
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Disease-Free Survival
  • Dose-Response Relationship, Drug
  • Gemcitabine
  • Humans
  • Hyperthermia, Induced / instrumentation
  • Hyperthermia, Induced / methods*
  • Indazoles
  • Multimodal Imaging*
  • Neoadjuvant Therapy
  • Positron-Emission Tomography*
  • Pyrimidines / administration & dosage
  • Randomized Controlled Trials as Topic
  • Sarcoma / diagnosis
  • Sarcoma / mortality
  • Sarcoma / pathology
  • Sarcoma / therapy*
  • Sirolimus / administration & dosage
  • Sirolimus / analogs & derivatives
  • Soft Tissue Neoplasms / diagnosis
  • Soft Tissue Neoplasms / mortality
  • Soft Tissue Neoplasms / pathology
  • Soft Tissue Neoplasms / therapy*
  • Sulfonamides / administration & dosage
  • Tomography, X-Ray Computed*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Indazoles
  • Pyrimidines
  • Sulfonamides
  • Deoxycytidine
  • ridaforolimus
  • Dacarbazine
  • pazopanib
  • Sirolimus
  • Gemcitabine